Reduction of cytotoxic effector cell activity in colon 38 tumours following treatment with flavone acetic acid

Atassi, 1985, Synthesis and antitumour activity of some 8-substituted 4-oxo-4H-1-benzopyrans, Eur J Med Chem, 5, 393 Kerr, 1988, Phase I and pharmacokinetic study of flavone acetic acid, Cancer Res, 47, 6776 Plowman, 1986, Flavone acetic acid: a novel agent with preclinical antitumor activity against colon adenocarcinoma 38 in mice, Cancer Treat Rep, 70, 631 Corbett, 1986, Solid tumor activity of flavone acetic acid (NSC 347512) against solid tumours of mice, Invest New Drugs, 4, 207, 10.1007/BF00179586 Finlay, 1988, Effect of flavone acetic acid (NSC 347512) on Lewis lung carcinoma: evidence for an indirect effect, J Natl Cancer Inst, 80, 241, 10.1093/jnci/80.4.241 Hornung, 1988, Immunomodulation of NK activity by flavone acetic acid occurs via induction of IFN2α/β, J Natl Cancer Inst, 80, 1226, 10.1093/jnci/80.15.1226 Ching, 1987, Induction of natural killer cell activity by the antitumour compound flavone acetic acid (NSC 347512), Eur J Cancer Clin Oncol, 23, 1047, 10.1016/0277-5379(87)90357-9 Wiltrout, 1988, Flavone-8-acetic acid augments systemic natural killer activity and synergizes with IL-2 or treatment of murine renal cancer, J Immunol, 9, 3261, 10.4049/jimmunol.140.9.3261 Hornung, 1988, Augmentation of natural killer (NK) activity, induction of interferon and development tumor immunity during the successful treatment of established murine renal cancer using flavone acetic acid (FAA) and interleukin-2, J Immunol, 141, 3671, 10.4049/jimmunol.141.10.3671 Ching, 1989, Effect of flavone acetic acid (NSC 347512) on splenic cytotoxic effector cells and their role in tumour necrosis, Eur J Cancer Clin Oncol, 25, 821, 10.1016/0277-5379(89)90127-2 Underwood, 1974, Lymphoreticular cell infiltration in human tumours: prognostic and histological implications, 30, 538 Smith, 1987, Flavone acetic acid (NSC 347512) induces haemorrhagic necrosis of mouse colon 26 and 38 tumours, Eur J Cancer Clin Oncol, 23, 1209, 10.1016/0277-5379(87)90157-X Cerottini, 1974, Generation of cytotoxic T lymphocytes in vitro. I. Response of normal and immune mouse spleen cells in mixed leukocyte cultures, J Exp Med, 140, 703, 10.1084/jem.140.3.703 Rosenstein, 1984, Lymphokine-activated killer cells: lysis of fresh syngeneic natural killer resistant murine tumour cells by lymphocytes cultured in interleukin 2, Cancer Res, 44, 1946 Kasai, 1980, A glycolipid on the surface of mouse natural killer cells, Eur J Immunol, 10, 175, 10.1002/eji.1830100304 Moy, 1985, Depression of natural killer cytotoxic activity in lymphocytes infiltrating human pulmonary tumors, Cancer Res, 45, 57 Itoh, 1986, Interleukin 2 activation of cytotoxic T-lymphocytes infiltrating into human metastatic melanomas, Cancer Res, 46, 3011 Yron, 1980, In vitro growth of murine T cells V, 125, 238 Milas, 1987, Macrophage content of murine sarcomas and carcinomas: associations with tumor growth parameters and tumor radiocurability, Cancer Res, 47, 1069 Eccles, 1974, Macrophage content in relation to metastatic spread and host immune reaction, Nature, 250, 667, 10.1038/250667a0 Talmadge, 1982, Macrophage content of metastatic and non-metastatic rodent neoplasms, J Immunol, 126, 2245, 10.4049/jimmunol.126.6.2245 Mantovani, 1985, Tumor-infiltrating leukocytes, Immunol Today, 6, 143, 10.1016/0167-5699(85)90134-3 Vujanovic, 1988, Lymphokine-activated killer cells in rats, 48, 884 Yang, 1986, Murine lymphokine-activated killer (LAK) cells: phenotypic characterization of the precursor effector cells, J Immunol, 137, 715, 10.4049/jimmunol.137.2.715 Ching, 1988, Enhancement of in vitro toxicity of mouse peritoneal exudate cells by flavone acetic acid (NSC 347512), Eur J Cancer Clin Oncol, 24, 1521, 10.1016/0277-5379(88)90345-8